rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1992-3-11
|
pubmed:abstractText |
Recent data from this laboratory indicate that pretreatment with adenosine can protect the heart against infarction via A1-receptors, but because of systemic hypotension, adenosine had to be given into the coronary circulation.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0009-7322
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
85
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
659-65
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:1735160-Adenosine,
pubmed-meshheading:1735160-Animals,
pubmed-meshheading:1735160-Coronary Disease,
pubmed-meshheading:1735160-Female,
pubmed-meshheading:1735160-Heart,
pubmed-meshheading:1735160-Hemodynamics,
pubmed-meshheading:1735160-Injections, Intravenous,
pubmed-meshheading:1735160-Male,
pubmed-meshheading:1735160-Myocardial Infarction,
pubmed-meshheading:1735160-Phenethylamines,
pubmed-meshheading:1735160-Phenylisopropyladenosine,
pubmed-meshheading:1735160-Rabbits
|
pubmed:year |
1992
|
pubmed:articleTitle |
Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction.
|
pubmed:affiliation |
Department of Physiology, University of South Alabama, Mobile 36688.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|